Drug intelligence / Profile preview

HIP1302

Development stage: Phase 1

Overview

HIP1302 is an investigational drug evaluated in a clinical trial for bioequivalence with HGP1406 in healthy male volunteers. The available information does not specify the active pharmaceutical ingredient or therapeutic class of HIP1302, nor its mechanism of action or primary indication. The study was designed to compare the pharmacokinetics and safety profiles of HIP1302 and HGP1406[1].

Beyond the preview

Go deeper on HIP1302.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on HIP1302.

Explore the full profile